Human immune response in schistosomiasis: The role of P24 in the modulation of cellular reactivity to Schistosoma mansoni antigens

Human Immunology

Volumn 63, Issue 8, 2002, Pages 647-656

  Soares Zouain, C laudia ^a   Gustavson, Shauma ^a   Silva Teixeira, David Nascimento ^b   Contigli, Christiane ^b   Rodrigues Jr, Virmondes ^b   De Fátima Leite, Maria ^a   Miranda Goes, Alfredo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Antigens; Cytokines; Granuloma; Modulation; Schistosomiasis; Vaccine

Indexed keywords

ANTIGEN P24; GAMMA INTERFERON; INTERLEUKIN 10; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTERFERON PRODUCTION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; ANIMAL; BIOSYNTHESIS; CASE CONTROL STUDY; CELLULAR IMMUNITY; FEMALE; GRANULOMA; IMMUNOLOGY; IN VITRO STUDY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL;

ANIMAL; ANTIGENS, HELMINTH; CASE-CONTROL STUDIES; FEMALE; GRANULOMA; HUMAN; IMMUNITY, CELLULAR; IN VITRO; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; ANIMALS; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036312212     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00422-6     Document Type: Article

References (53)

1. Mild prolonged schistosomiasis in mice: Alteration in host response with time and the development of portal fibrosis
2. Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. III. In vitro granuloma modulation induced by immune complexes
3. Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production
4. Down modulation of MHC surface molecules on B cells by suppressive immune complexes obtained from chronic intestinal schistosomiasis patients
5. Prospects of vaccination against schistosomiasis
6. The search for a vaccine against schistosomiasis - A difficult path but an achievable goal
7. Resistance to Schistosoma mansoni in humans: Influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy
8. Human immune responses to Schistosoma mansoni vaccine candidate antigens
9. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium
10. Susceptibility and resistance to Schistosoma mansoni reinfection: Parallel cellular and isotypic immunologic assessment
11. Characterization of Schistosoma mansoni 44.7/56.8 kDa egg antigens recognized by human monoclonal antibodies, which induce protection against experimental infection and proliferation of peripheral blood mononuclear cells from schistosomiasis patients
12. Immune responses to the radiation-attenuated schistosome vaccine: What can we learn from knock-out mice?
13. The role of IL-10 and IgG1 in the protection and granulomatous response in Schistosoma mansoni P24-immunized mice
14. cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase
15. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triosephosphate isomerase
16. Molecular cloning of a protective antigen of schistosomes
17. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni
18. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97) a non-surface parasite antigen
19. An immunogenic Mr 23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen
20. Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoni
21. Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni
22. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are ThO/2
23. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes
24. Cytokine regulation of human immune response to Schistosoma mansoni: Analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses
25. Human peripheral blood mononuclear cells stimulated by S. mansoni antigens: Association between protein tyrosine kinases, mitogen-activated protein kinases and cytokine production
26. Human antibody responses to Schistosoma mansoni: The influence of epitopes shared between different life-cycle stages on the response to the schistosomulum
27. Induction of protective immunity and modulation of granulomatous hypersensitivity in mice using PIII, an anionic fraction of Schistosoma mansoni adult worm
28. Characterization of fractionated Schistosoma mansoni soluble adult worm antigens that elicit human cell proliferation and granuloma formation in vitro
29. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni
30. Production and characterization of human monoclonal antibodies against Schistosoma mansoni
31. Delayed hypersensitivity granuloma formation around Schistosoma mansoni eggs in vitro. III. Granuloma formation and modulation in human schistosomiasis mansoni
32. Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. I. Granuloma formation and modulation around polyacrylamide antigen-conjugated beads
33. Research brief: Schistosoma mansoni: Immunization with cercarial glycocalyx preparation increases adult worm burden
34. T-cell responsiveness towards various synthetic peptides of the P28 antigen in rat and mouse models during Schistosoma mansoni infection
35. Development of a vaccine strategy against human and bovine schistosomiais. Background and update
36. Prospects for immunological control of schistosomiais
37. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: Potential basis of a multi-valent anti-helminth vaccine?
38. The radiation-attenuated vaccine against schistosomes in animal models: Paradigm for a human vaccine?
39. Rats, mice and men - Models for immune effector mechanisms against schistosomiasis
40. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibodies responses contribute equally to vaccine-induced immunity to Schistosoma manssoni
41. Nitric oxide interaction with IL-10, MIP-lalpha, MCP-1 and RANTES over the in vitro granuloma formation against different Schistosoma mansoni antigenic preparations on human schistosomiasis
42. Induction of protective immunity against Schistosoma mansoni infection by antigens purified from PIII, a fraction of adult worm, associated to the downregulation of granuloma formation
43. Nitric oxide and IL-10 production induced by PIII-a fraction of Schistosoma mansoni adult worm antigenic preparation associated with downregulation of in vitro granuloma formation
44. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
45. Human schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation
46. Cytokine production in acute versus chronic human Schistosomiasis mansoni: The cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens
47. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
48. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7-1 and B7-2 costimulatory molecules by macrophages
49. Inducible nitric oxide synthase: What difference does it make?
50. Immunization with PIII, a fraction of Schistosoma mansoni soluble adult worm antigenic preparation, affects nitric oxide production by murine spleen cells
51. Cytokine profile associated to effector functions of human T cell clones specific for Schistosoma mansoni antigens
52. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni
53. Tumour necrosis factor in hepatosplenic schistosomiasis